DK1830857T3 - Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom - Google Patents

Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom

Info

Publication number
DK1830857T3
DK1830857T3 DK05856121.8T DK05856121T DK1830857T3 DK 1830857 T3 DK1830857 T3 DK 1830857T3 DK 05856121 T DK05856121 T DK 05856121T DK 1830857 T3 DK1830857 T3 DK 1830857T3
Authority
DK
Denmark
Prior art keywords
days
prednisone
graft
versus
mortality associated
Prior art date
Application number
DK05856121.8T
Other languages
Danish (da)
English (en)
Inventor
George B Mcdonald
Steve Kanzer
Nicholas Stergis
Original Assignee
Soligenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soligenix Inc filed Critical Soligenix Inc
Application granted granted Critical
Publication of DK1830857T3 publication Critical patent/DK1830857T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05856121.8T 2004-12-30 2005-12-30 Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom DK1830857T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64017804P 2004-12-30 2004-12-30
PCT/US2005/047666 WO2006072093A2 (en) 2004-12-30 2005-12-30 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone

Publications (1)

Publication Number Publication Date
DK1830857T3 true DK1830857T3 (da) 2011-02-07

Family

ID=36615583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05856121.8T DK1830857T3 (da) 2004-12-30 2005-12-30 Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom

Country Status (13)

Country Link
US (1) US20060252735A1 (https=)
EP (1) EP1830857B1 (https=)
JP (1) JP2008526773A (https=)
KR (1) KR20070089701A (https=)
CN (2) CN101060848B (https=)
AT (1) ATE481102T1 (https=)
AU (1) AU2005321826B2 (https=)
CA (1) CA2583244A1 (https=)
DE (1) DE602005023655D1 (https=)
DK (1) DK1830857T3 (https=)
IL (1) IL182462A0 (https=)
NZ (1) NZ554326A (https=)
WO (1) WO2006072093A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
SG10201704531XA (en) * 2008-12-08 2017-07-28 Soligenix Inc Topically active steroids for use in radiation and chemotherapeutics injury
US20170209447A1 (en) * 2014-08-07 2017-07-27 Nitor Therapeutics Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant
CN106236736A (zh) * 2016-09-26 2016-12-21 安徽省逸欣铭医药科技有限公司 二丙酸倍氯米松肠溶缓释片及其制备方法
EP4073100A4 (en) 2019-12-09 2024-02-14 Syndax Pharmaceuticals, Inc. ANTIBODIES FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
US6096731A (en) * 1998-06-24 2000-08-01 Institute For Drug Research, Inc. Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
US20030032631A1 (en) 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
JP4014912B2 (ja) * 2001-09-28 2007-11-28 株式会社ルネサステクノロジ 半導体装置

Also Published As

Publication number Publication date
WO2006072093A3 (en) 2007-03-22
CN101060848A (zh) 2007-10-24
EP1830857B1 (en) 2010-09-15
EP1830857A4 (en) 2008-02-27
KR20070089701A (ko) 2007-08-31
EP1830857A2 (en) 2007-09-12
NZ554326A (en) 2010-10-29
ATE481102T1 (de) 2010-10-15
AU2005321826A1 (en) 2006-07-06
CA2583244A1 (en) 2006-07-06
JP2008526773A (ja) 2008-07-24
AU2005321826B2 (en) 2012-03-15
US20060252735A1 (en) 2006-11-09
WO2006072093A2 (en) 2006-07-06
DE602005023655D1 (de) 2010-10-28
IL182462A0 (en) 2008-04-13
CN101060848B (zh) 2011-06-22
CN102218070A (zh) 2011-10-19

Similar Documents

Publication Publication Date Title
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
NZ606825A (en) Methods and compositions for treating complement-associated disorders
EP2512479A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
UA99152C2 (ru) Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
TW200833367A (en) Pharmaceutical compositions and method for treating inflammation in cattle and other animals
IL182462A0 (en) Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
JP2016509050A5 (https=)
JP2005504018A5 (https=)
NO20080244L (no) Doseringsstyring for prasugrel
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
MX2022012001A (es) Tratamiento preventivo de la migra?a.
MY166524A (en) Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy
EA200601286A1 (ru) Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
MX2022016410A (es) Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un antagonista del pd-1, inhibidor de hif-2 alpha y lenvatinib o una sal aceptable farmeuticamente de estos.
WO2021262562A3 (en) Methods for treating cancer or von-hippel lindau disease using a combination of a pd-1 antagonist, a hif-2 alpha inhibitor, and lenvatinib or a pharmaceutically acceptable salt thereof
MY148085A (en) Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
AR075345A1 (es) Tratamiento con glucocorticoides de liberacion retardada de artritis reumatoidea que mejora signos y sintomas, muestra respuesta clinica total o completa y previene el dano a las articulaciones
WO2008121461A3 (en) Vaccine for activating helper function of cd8+ tcells
JP2002544167A5 (https=)
CN104324018B (zh) 广藿香醇在制备男性性功能障碍药物或保健品中的应用
WO2008143014A1 (ja) がん治療剤